BMS launches new biologics discovery facility 27th April 2018
Bristol-Myers Squibb is launching operations at the newest building to its Redwood City research and development campus in California, USA.
The newly-opened site is to serve as Bristol-Myers Squibb’s biologics discovery centre, focusing primarily on cancer-immunotherapies, which manipulate the immune system so that the body’s own defensive network recognizes and attacks tumours. The expansion adds a third building—housing just over 300 employees—to Bristol-MyersSquibb’s Bay Area hub for discovering pioneering cancer therapies, bringing the company’s local footprint to 256,000 square feet.
The new facility is designed to set a new standard in energy and water efficiency, and is the first Bristol-Myers Squibb site to undertake the Energy Star Challenge for Industry — a program that requires a 10% reduction in energy usage over the next 5 years. Global design firm Stantec provided architecture, interior design, lab planning, and complete engineering on the 62,000-square-foot structure.